Nav: Home

American Society of Tropical Medicine and Hygiene 65th Annual Meeting

October 12, 2016

American Society of Tropical Medicine and Hygiene 65th Annual Meeting
November 13 - 17, 2016, Atlanta, Georgia, USA
On Twitter: #TropMed16

Latest on Zika in the Americas, Yellow Fever's
Comeback in Africa, A Vaccine Against Traveler's Diarrhea,
Ebola Vaccines, and Cutting-Edge Malaria Research

Special Session and Interactive Experience on Refugee Health
Leader of Zika Fight, Dr. Carissa Etienne, Director of the Pan-American Health Organization (PAHO) to Keynote

The world faces an assortment of new and re-emerging infectious disease threats, and scientists are working hard to develop a new arsenal of powerful interventions. Thousands of these disease experts will gather in Atlanta for the 65th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), the world's largest gathering of tropical medicine experts. Opening the conference is Dr. Carissa F. Etienne, the Director General of the Pan-American Health Organization (PAHO) and a leader of the global fight against the Zika outbreak.

Commonly known as TropMed, the ASTMH Annual Meeting also will feature the latest findings on an alarming resurgence of yellow fever in Africa that has resulted in nearly 6,000 cases and over 400 deaths to-date and the potential to use a powerful but controversial gene-editing tool to combat parasites like malaria. Additionally, ASTMH and the U.S. Centers for Disease Control and Prevention (CDC), with a number of U.S. and international partners, will present a unique interactive experience focusing on refugee health and resettlement. A special panel discussion will also be held Tuesday evening: The Refugee Journey to Wellbeing.

WHAT: The American Society of Tropical Medicine and Hygiene 65th Annual Meeting

WHEN: November 13 - 17, 2016 (Sunday through Thursday)

WHERE: Atlanta Marriott Marquis and Hilton Atlanta

KEYNOTE: Dr. Carissa Etienne, Director General, Pan American Health Organization

RSVP: For more information and to register for press credentials, please contact:ONLINE: On Twitter @astmh #TropMed16

Selected Highlights of the ASTMH 2016 Annual Meeting Include:

A Delete Key for Parasitic Diseases: New research will be shared on the potential to use a novel and powerful gene-editing tool called CRISPR to fight a range of dangerous parasites, including those that cause malaria and leishmaniasis. CRISPR allows scientists to selectively alter the genetic code of almost any organism.

Getting Beyond Pepto-Bismol: Researchers will present the latest evidence on efforts to develop a vaccine against Enterotoxigenic E. coli, or ETEC, an important cause of life-threatening diarrheal illness among children in the developing world and the most common cause of the vacation scourge known as "traveler's diarrhea."

Kicking Ebola While It's Down: With Ebola contained but not eliminated, scientists will present evidence for using new Ebola vaccines now under development to fight future outbreaks. They also will share new research assessing the health status of Ebola survivors and probing the puzzling possibility of Ebola infections that cause no symptoms.

Malaria Elimination in the Americas: Scientists will present new data that indicates that conditions may be ripe for eliminating malaria from the Americas - as well as the challenges to cross the finish line - with surveillance and strategies to target remaining pockets of disease.

K-Pop and the Future of Disease Tracking: Internet discussion groups focusing on Korean pop music, or K-Pop, played an unexpected but appreciated role in providing updates on the 2015 outbreak in Korea of the deadly Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Scientists will take a closer look at how tweets, texts and other forms of social media offer new options to track disease outbreaks in real time.

Batting Around a Potential Health Emergency: Scientists will present research probing concerns that the spread of the dangerous Nipah virus by bats in Bangladesh could produce a strain of the disease that's highly transmissible from human to human and could spark a public health emergency.

Diseases Other than Zika that May Impact Fetal Health: Zika is not the only mosquito-borne disease posing risks to children in utero and in early infancy. Researchers will share the latest insights into problems that could occur when pregnant women are infected with chikungunya or malaria.

Unique Interactive Experience plus Tuesday Evening Session: The Refugee Journey to Wellbeing

At the end of 2015, there were an estimated 65.3 million people displaced around the world, mainly due to extended conflicts in the Middle East, Northern and sub-Saharan Africa, and Asia. ASTMH and the U.S. Centers for Disease Control and Prevention (CDC), with participation from a number of U.S. and international partners, will host a unique interactive experience on refugee health and resettlement. Through video, photos, live testimonials, hands-on activities, and replicated scenes from the field, this exhibit will highlight the clinical and public health aspects of the refugee experience from displacement to resettlement. Additionally, a Tuesday evening session: The Refugee Journey to Wellbeing, will feature speakers from CDC, the United Nations High Commissioner for Refugees, International Organization for Migration, and Médecins Sans Frontières discussing care efforts, successes and challenges to the healthy resettlement of refugees.


Related Malaria Articles:

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the Umeå University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.
Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.
New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
More Malaria News and Malaria Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#544 Prosperity Without Growth
The societies we live in are organised around growth, objects, and driving forward a constantly expanding economy as benchmarks of success and prosperity. But this growing consumption at all costs is at odds with our understanding of what our planet can support. How do we lower the environmental impact of economic activity? How do we redefine success and prosperity separate from GDP, which politicians and governments have focused on for decades? We speak with ecological economist Tim Jackson, Professor of Sustainable Development at the University of Surrey, Director of the Centre for the Understanding of Sustainable Propserity, and author of...
Now Playing: Radiolab

An Announcement from Radiolab